Co-pay accumulator adjustment programs are meant to ensure that individuals are responsible for the full amount of their insurance deductible, which should help promote healthcare consumerism, according to Bruce Sherman, MD, chief medical officer of the National Alliance of Healthcare Purchaser Coalitions.
Co-pay accumulator adjustment programs are meant to ensure that individuals are responsible for the full amount of their insurance deductible, which should help promote healthcare consumerism, according to Bruce Sherman, MD, chief medical officer of the National Alliance of Healthcare Purchaser Coalitions.
Transcript
What are co-pay accumulator programs and what purpose are they supposed to serve?
The intent of co-pay accumulator programs is to ensure that individuals who elect to enroll in a high-deductible or consumer-directed health plan fulfill the obligation of their enrollment in that plan to pay for the deductible in its full amount before the health plan or the benefit plan kicks in to support their healthcare needs.
The co-pay accumulator adjustment programs serve to prevent individuals from having any funds credited toward their deductible that come from an outside entity, such as a pharmaceutical manufacturer, that prior to about 2017 were being counted toward the patient contribution. Now with the implementation of co-pay accumulator adjustment programs, the [pharmacy benefit managers] are able to identify the source of funds, whether they are coming from the patients, whether they’re coming from a third-party source, and attribute those to the deductible or not based on the particular plan design.
So the accumulator program specifically is intended to prevent any contribution from outside of the patient from being credited toward the individual’s deductible, and that, at least theoretically, should help promote healthcare consumerism by ensuring that patients are responsible for that full amount of the deductible as the plan depicts.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More